Dietary Supplements Market (By Type: Vitamins, Minerals, Fibers & Specialty Carbohydrates, Omega Fatty Acids, Botanicals, Proteins & Amino Acids, and Others; By Form: Capsules, Tablets, Gummies, Soft gels, Liquids, Powders, and Others; By Application: General Health, Energy & Weight Management, Gastrointestinal Health, Diabetes, Bone & Joint Health, Immunity, Cardiac Health, Anti-cancer, and Others; By End User) - Global Industry Analysis, Size, Share, Growth, Forecast 2024 - 2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Dietary Supplements Market, By Ingredient
7.1. Dietary Supplements Market, by Ingredient, 2023-2032
7.1.1. Vitamins
7.1.1.1. Market Revenue and Forecast (2021-2032)
7.1.2. Minerals
7.1.2.1. Market Revenue and Forecast (2021-2032)
7.1.3. Fibers & Specialty Carbohydrates
7.1.3.1. Market Revenue and Forecast (2021-2032)
7.1.4. Omega Fatty Acids
7.1.4.1. Market Revenue and Forecast (2021-2032)
7.1.5. Botanicals
7.1.5.1. Market Revenue and Forecast (2021-2032)
7.1.6. Proteins & Amino Acids
7.1.6.1. Market Revenue and Forecast (2021-2032)
7.1.7. Others
7.1.7.1. Market Revenue and Forecast (2021-2032)
Chapter 8. Global Dietary Supplements Market, By Form
8.1. Dietary Supplements Market, by Form, 2023-2032
8.1.1. Capsules
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Tablets
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Gummies
8.1.3.1. Market Revenue and Forecast (2021-2032)
8.1.4. Soft gels
8.1.4.1. Market Revenue and Forecast (2021-2032)
8.1.5. Liquids
8.1.5.1. Market Revenue and Forecast (2021-2032)
8.1.6. Powders
8.1.6.1. Market Revenue and Forecast (2021-2032)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Dietary Supplements Market, By Application
9.1. Dietary Supplements Market, by Application, 2023-2032
9.1.1. Energy & Weight Management
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Bone & Joint Health
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Diabetes
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. General Health
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.5. Immunity
9.1.5.1. Market Revenue and Forecast (2021-2032)
9.1.6. Cardiac Health
9.1.6.1. Market Revenue and Forecast (2021-2032)
9.1.7. Gastrointestinal Health
9.1.7.1. Market Revenue and Forecast (2021-2032)
9.1.8. Anti-cancer
9.1.8.1. Market Revenue and Forecast (2021-2032)
9.1.9. Lungs Detox/Cleanse
9.1.9.1. Market Revenue and Forecast (2021-2032)
9.1.10. Sexual Health
9.1.10.1. Market Revenue and Forecast (2021-2032)
9.1.11. Brain/Mental Health
9.1.11.1. Market Revenue and Forecast (2021-2032)
9.1.12. Skin/Hair/Nails
9.1.12.1. Market Revenue and Forecast (2021-2032)
9.1.13. Insomnia
9.1.13.1. Market Revenue and Forecast (2021-2032)
9.1.14. Anti-aging
9.1.14.1. Market Revenue and Forecast (2021-2032)
9.1.15. Menopause
9.1.15.1. Market Revenue and Forecast (2021-2032)
9.1.16. Prenatal Health
9.1.16.1. Market Revenue and Forecast (2021-2032)
9.1.17. Others
9.1.17.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Dietary Supplements Market, By End User
10.1. Dietary Supplements Market, by End User, 2023-2032
10.1.1. Adults
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Geriatric
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Pregnant Women
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Children
10.1.4.1. Market Revenue and Forecast (2021-2032)
10.1.5. Infants
10.1.5.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Dietary Supplements Market, By Type
11.1. Dietary Supplements Market, by Type, 2023-2032
11.1.1. OTC
11.1.1.1. Market Revenue and Forecast (2021-2032)
11.1.2. Prescribed
11.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 12. Global Dietary Supplements Market, By Distribution Channel
12.1. Dietary Supplements Market, by Distribution Channel, 2023-2032
12.1.1. Offline
12.1.1.1. Market Revenue and Forecast (2021-2032)
12.1.2. Hypermarkets/Supermarkets
12.1.2.1. Market Revenue and Forecast (2021-2032)
12.1.3. Pharmacies
12.1.3.1. Market Revenue and Forecast (2021-2032)
12.1.4. Specialty Stores
12.1.4.1. Market Revenue and Forecast (2021-2032)
12.1.5. Practioner
12.1.5.1. Market Revenue and Forecast (2021-2032)
12.1.6. Others
12.1.6.1. Market Revenue and Forecast (2021-2032)
12.1.7. Online
12.1.7.1. Market Revenue and Forecast (2021-2032)
Chapter 13. Global Dietary Supplements Market, By Function
13.1. Dietary Supplements Market, by Function, 2023-2032
13.1.1. Additional supplements
13.1.1.1. Market Revenue and Forecast (2021-2032)
13.1.2. Medicinal supplements
13.1.2.1. Market Revenue and Forecast (2021-2032)
13.1.3. Sports nutrition
13.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 14. Global Dietary Supplements Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.1.2. Market Revenue and Forecast, by Form (2021-2032)
14.1.3. Market Revenue and Forecast, by Application (2021-2032)
14.1.4. Market Revenue and Forecast, by End User (2021-2032)
14.1.5. Market Revenue and Forecast, by Type (2021-2032)
14.1.6. Market Revenue and Forecast, by Function (2021-2032)
14.1.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.1.8.2. Market Revenue and Forecast, by Form (2021-2032)
14.1.8.3. Market Revenue and Forecast, by Application (2021-2032)
14.1.8.4. Market Revenue and Forecast, by End User (2021-2032)
14.1.8.5. Market Revenue and Forecast, by Type (2021-2032)
14.1.8.6. Market Revenue and Forecast, by Function (2021-2032)
14.1.8.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.1.9.2. Market Revenue and Forecast, by Form (2021-2032)
14.1.9.3. Market Revenue and Forecast, by Application (2021-2032)
14.1.9.4. Market Revenue and Forecast, by End User (2021-2032)
14.1.9.5. Market Revenue and Forecast, by Type (2021-2032)
14.1.9.6. Market Revenue and Forecast, by Function (2021-2032)
14.1.9.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.2.2. Market Revenue and Forecast, by Form (2021-2032)
14.2.3. Market Revenue and Forecast, by Application (2021-2032)
14.2.4. Market Revenue and Forecast, by End User (2021-2032)
14.2.5. Market Revenue and Forecast, by Type (2021-2032)
14.2.6. Market Revenue and Forecast, by Function (2021-2032)
14.2.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.2.8.2. Market Revenue and Forecast, by Form (2021-2032)
14.2.8.3. Market Revenue and Forecast, by Application (2021-2032)
14.2.8.4. Market Revenue and Forecast, by End User (2021-2032)
14.2.8.5. Market Revenue and Forecast, by Type (2021-2032)
14.2.8.6. Market Revenue and Forecast, by Function (2021-2032)
14.2.8.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.2.9.2. Market Revenue and Forecast, by Form (2021-2032)
14.2.9.3. Market Revenue and Forecast, by Application (2021-2032)
14.2.9.4. Market Revenue and Forecast, by End User (2021-2032)
14.2.9.5. Market Revenue and Forecast, by Type (2021-2032)
14.2.9.6. Market Revenue and Forecast, by Function (2021-2032)
14.2.9.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.2.10.2. Market Revenue and Forecast, by Form (2021-2032)
14.2.10.3. Market Revenue and Forecast, by Application (2021-2032)
14.2.10.4. Market Revenue and Forecast, by End User (2021-2032)
14.2.10.5. Market Revenue and Forecast, by Type (2021-2032)
14.2.10.6. Market Revenue and Forecast, by Function (2021-2032)
14.2.10.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.2.11.2. Market Revenue and Forecast, by Form (2021-2032)
14.2.11.3. Market Revenue and Forecast, by Application (2021-2032)
14.2.11.4. Market Revenue and Forecast, by End User (2021-2032)
14.2.11.5. Market Revenue and Forecast, by Type (2021-2032)
14.2.11.6. Market Revenue and Forecast, by Function (2021-2032)
14.2.11.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.3.2. Market Revenue and Forecast, by Form (2021-2032)
14.3.3. Market Revenue and Forecast, by Application (2021-2032)
14.3.4. Market Revenue and Forecast, by End User (2021-2032)
14.3.5. Market Revenue and Forecast, by Type (2021-2032)
14.3.6. Market Revenue and Forecast, by Function (2021-2032)
14.3.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.3.8.2. Market Revenue and Forecast, by Form (2021-2032)
14.3.8.3. Market Revenue and Forecast, by Application (2021-2032)
14.3.8.4. Market Revenue and Forecast, by End User (2021-2032)
14.3.8.5. Market Revenue and Forecast, by Type (2021-2032)
14.3.8.6. Market Revenue and Forecast, by Function (2021-2032)
14.3.8.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.3.9.2. Market Revenue and Forecast, by Form (2021-2032)
14.3.9.3. Market Revenue and Forecast, by Application (2021-2032)
14.3.9.4. Market Revenue and Forecast, by End User (2021-2032)
14.3.9.5. Market Revenue and Forecast, by Type (2021-2032)
14.3.9.6. Market Revenue and Forecast, by Function (2021-2032)
14.3.9.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.3.10.2. Market Revenue and Forecast, by Form (2021-2032)
14.3.10.3. Market Revenue and Forecast, by Application (2021-2032)
14.3.10.4. Market Revenue and Forecast, by End User (2021-2032)
14.3.10.5. Market Revenue and Forecast, by Type (2021-2032)
14.3.10.6. Market Revenue and Forecast, by Function (2021-2032)
14.3.10.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.3.11.2. Market Revenue and Forecast, by Form (2021-2032)
14.3.11.3. Market Revenue and Forecast, by Application (2021-2032)
14.3.11.4. Market Revenue and Forecast, by End User (2021-2032)
14.3.11.5. Market Revenue and Forecast, by Type (2021-2032)
14.3.11.6. Market Revenue and Forecast, by Function (2021-2032)
14.3.11.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.4.2. Market Revenue and Forecast, by Form (2021-2032)
14.4.3. Market Revenue and Forecast, by Application (2021-2032)
14.4.4. Market Revenue and Forecast, by End User (2021-2032)
14.4.5. Market Revenue and Forecast, by Type (2021-2032)
14.4.6. Market Revenue and Forecast, by Function (2021-2032)
14.4.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.4.8.2. Market Revenue and Forecast, by Form (2021-2032)
14.4.8.3. Market Revenue and Forecast, by Application (2021-2032)
14.4.8.4. Market Revenue and Forecast, by End User (2021-2032)
14.4.8.5. Market Revenue and Forecast, by Type (2021-2032)
14.4.8.6. Market Revenue and Forecast, by Function (2021-2032)
14.4.8.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.4.9.2. Market Revenue and Forecast, by Form (2021-2032)
14.4.9.3. Market Revenue and Forecast, by Application (2021-2032)
14.4.9.4. Market Revenue and Forecast, by End User (2021-2032)
14.4.9.5. Market Revenue and Forecast, by Type (2021-2032)
14.4.9.6. Market Revenue and Forecast, by Function (2021-2032)
14.4.9.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.4.10.2. Market Revenue and Forecast, by Form (2021-2032)
14.4.10.3. Market Revenue and Forecast, by Application (2021-2032)
14.4.10.4. Market Revenue and Forecast, by End User (2021-2032)
14.4.10.5. Market Revenue and Forecast, by Type (2021-2032)
14.4.10.6. Market Revenue and Forecast, by Function (2021-2032)
14.4.10.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.4.11.2. Market Revenue and Forecast, by Form (2021-2032)
14.4.11.3. Market Revenue and Forecast, by Application (2021-2032)
14.4.11.4. Market Revenue and Forecast, by End User (2021-2032)
14.4.11.5. Market Revenue and Forecast, by Type (2021-2032)
14.4.11.6. Market Revenue and Forecast, by Function (2021-2032)
14.4.11.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.5.2. Market Revenue and Forecast, by Form (2021-2032)
14.5.3. Market Revenue and Forecast, by Application (2021-2032)
14.5.4. Market Revenue and Forecast, by End User (2021-2032)
14.5.5. Market Revenue and Forecast, by Type (2021-2032)
14.5.6. Market Revenue and Forecast, by Function (2021-2032)
14.5.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.5.8.2. Market Revenue and Forecast, by Form (2021-2032)
14.5.8.3. Market Revenue and Forecast, by Application (2021-2032)
14.5.8.4. Market Revenue and Forecast, by End User (2021-2032)
14.5.8.5. Market Revenue and Forecast, by Type (2021-2032)
14.5.8.6. Market Revenue and Forecast, by Function (2021-2032)
14.5.8.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Ingredient (2021-2032)
14.5.9.2. Market Revenue and Forecast, by Form (2021-2032)
14.5.9.3. Market Revenue and Forecast, by Application (2021-2032)
14.5.9.4. Market Revenue and Forecast, by End User (2021-2032)
14.5.9.5. Market Revenue and Forecast, by Type (2021-2032)
14.5.9.6. Market Revenue and Forecast, by Function (2021-2032)
14.5.9.7. Market Revenue and Forecast, by Distribution Channel (2021-2032)
Chapter 15. Company Profiles
15.1. Bayer
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. NBTY Inc
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Bionova Lifesciences
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Nu Skin Enterprises
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Carlyle Group
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Pfizer
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Arkopharma Laboratoires Pharmaceutiques
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Glanbia
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Herbalife International
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Abbott Laboratories
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client